Daniel D. Burton, Chief Executive Officer at Health Catalyst, Inc. (HCAT), sold 87,508 shares at $54.54 ($4.8M) on 2021-06-07, disclosed to the SEC on 2021-06-09.
Open-market sale of $4.8M HCAT by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $53.72 | 11,105 | $597K | 12.3% |
| 2 | $53.72 | 11,105 | $597K | 12.3% |
| 3 | $54.54 | 2,992 | $163K | 3.4% |
| 4 | $54.54 | 2,992 | $163K | 3.4% |
| 5 | $55.80 | 38,460 | $2.1M | 44.4% |
| 6 | $56.23 | 10,427 |
| $586K |
| 12.1% |
| 7 | $56.23 | 10,427 | $586K | 12.1% |
| Total | $55.29 avg | 87,508 | $4.8M | 100% |
| Filing → |
| HCAT | BUY | 2022-11-14 | $4.0M | — | Filing → |
| HCAT | BUY | 2022-09-08 | $2.0M | — | Filing → |
| HCAT | BUY | 2022-08-09 | $4.1M | — | Filing → |